Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5219
DC FieldValueLanguage
dc.contributor.authorEl Hachem, Georgesen_US
dc.contributor.authorGombos, Andreaen_US
dc.contributor.authorAwada, Ahmaden_US
dc.date.accessioned2021-12-09T09:34:57Z-
dc.date.available2021-12-09T09:34:57Z-
dc.date.issued2021-
dc.identifier.issn14737140-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/5219-
dc.description.abstractThe field of metastatic luminal breast cancer (hormone receptor positive, HER-2 negative) is dynamic and evolving, harboring some of the most significant therapeutic advances in medical oncology. Over the last decade, many pivotal trials showed excellent results with drastic improvements in survival as well as the quality of life of metastatic luminal breast cancer patients.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Onlineen_US
dc.subjectCDK 4/6 inhibitorsen_US
dc.subjectLuminal breast canceren_US
dc.subjectAbemacicliben_US
dc.subjectBrain metastasesen_US
dc.subjectHormone receptor positiveen_US
dc.titleAbemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast canceren_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1080/14737140.2020.1834385-
dc.identifier.pmid33054442-
dc.identifier.scopus2-s2.0-85097407790-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85097407790-
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume21en_US
dc.description.issue1en_US
dc.description.startpage81en_US
dc.description.endpage92en_US
dc.date.catalogued2021-12-09-
dc.description.statusPublisheden_US
dc.identifier.ezproxyURLhttp://ezsecureaccess.balamand.edu.lb/login?url=https://www.tandfonline.com/doi/full/10.1080/14737140.2020.1834385en_US
dc.relation.ispartoftextExpert Review of Anticancer Therapyen_US
dc.description.campusSGH campusen_US
Appears in Collections:Faculty of Medicine
Show simple item record

SCOPUSTM   
Citations

8
checked on Nov 16, 2024

Record view(s)

71
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.